DETRUSITOL

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DETRUSITOL contains one active pharmaceutical ingredient (API):

1 Tolterodine UNII 5T619TQR3R - TOLTERODINE TARTRATE

Tolterodine is a competitive, specific muscarinic receptor antagonist with selectivity for the urinary bladder over salivary glands in vivo. Read about Tolterodine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD07	Tolterodine	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 552820050066717
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00234672, 01811290, 01812390, 01812409, 03161873, 04707009, 06306562, 07631620, 08624384, 08759931, 08759954, 08922489, 08922503, 11580420, 11580437, 11580443, 13899746
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.632-1-11-11, 30072-12-11
Country: EE	Ravimiamet	Identifier(s): 1043301, 1043312, 1064146, 1064157
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 2383602, 62022, 64245
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002531, 004891, 048827
Country: FR	Base de données publique des médicaments	Identifier(s): 64617270
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138639, 138642, 138644, 143057, 143067, 143072, 19968, 19970, 373747, 398233
Country: HK	Department of Health Drug Office	Identifier(s): 43721, 43722, 66981, 66982
Country: IE	Health Products Regulatory Authority	Identifier(s): 20469, 20470, 53615, 53617, 53627, 53651, 53662, 53693
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4533, 4534
Country: JP	医薬品医療機器総合機構	Identifier(s): 2590012M1021, 2590012M2028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004484, 1004538, 1005550, 1026187, 1026188, 1037880, 1037882, 1072504, 1092956, 1092957
Country: MT	Medicines Authority	Identifier(s): MA1396/00501, MA1396/00502
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 176M98, 194M2004
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50334, 50342, 60534, 66842
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8037, 8038
Country: SG	Health Sciences Authority	Identifier(s): 09911P, 09912P, 11857P, 11859P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7963061, 7963062
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532014092, 8699532178169, 8699532178404, 8699759090022, 8699759090046
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/5.1/0449, 36/5.4/0448